Novavax, Inc. (NASDAQ:NVAX) Receives $17.83 Average Price Target from Brokerages
Novavax, Inc. (NASDAQ:NVAX – Get Free Report) has been assigned a consensus rating of “Hold” from the six ratings firms that are presently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and three have assigned a buy recommendation to the […]
Novavax, Inc. (NASDAQ:NVAX – Get Free Report) has been assigned a consensus rating of “Hold” from the six ratings firms that are presently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and three have assigned a buy recommendation to the […]
